Hee-Young Park, PhD

Professor, Medical Sciences & Education

Hee-Young Park
(617) 638-5527
72 E. Concord St Instructional (L)

Biography

Dr. Hee-Young Park, Assistant Dean of GMS and a faculty member of the Dermatology and Biochemistry departments, received both B.S. and Ph.D. degrees from MIT. Born in Seoul, Korea, Dr. Park moved to Sapporo, Japan with her family for middle school. She then came to Fayetteville, Arkansas for high school and remained in the U.S. to pursue her interests in science. Dr. Park’s research for past two decades has focused on signaling pathways and factors that control skin color, aging and cutaneous wound healing. In addition to her research activities, she has consulted cosmetic and pharmaceutical companies interested in developing treatments for pigmentation-disorders and holds a patent for a method to decrease skin pigmentation. Dr. Park also has a long-standing interest in teaching and mentoring students. She has served as a faculty advisor and mentor to graduate students, medical students, residents and post-doctoral fellows. She hopes to continue to devote her time to serving the GMS community and helping all GMS students to have enriched educational experiences that will best prepare them for their future careers.

Other Positions

  • Professor, Dermatology (excluding Mohs Surgery), Dermatology, Boston University School of Medicine
  • Assistant Dean, Boston University School of Medicine, Division of Graduate Medical Sciences
  • Chair, Medical Sciences & Education, Boston University School of Medicine
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Division of Graduate Medical Sciences

Education

  • Massachusetts Institute of Technology, PhD
  • Massachusetts Institute of Technology, BS

Publications

  • Published on 12/1/2014

    Mitchell B, Leone D, Feller JK, Bondzie P, Yang S, Park HY, Mahalingam M. Correlation of chemokine receptor CXCR4 mRNA in primary cutaneous melanoma with established histopathologic prognosticators and the BRAF status. Melanoma Res. 2014 Dec; 24(6):621-5. PMID: 25211166.

    Read at: PubMed
  • Published on 10/1/2014

    Belisle ES, Park HY. Metformin: a potential drug to treat hyperpigmentation disorders. J Invest Dermatol. 2014 Oct; 134(10):2488-91. PMID: 25219649.

    Read at: PubMed
  • Published on 7/2/2014

    Mitchell B, Leone D, Feller K, Menon S, Bondzie P, Yang S, Park HY, Mahalingam M. Protein expression of the chemokine receptor CXCR4 and its ligand CXCL12 in primary cutaneous melanoma--biomarkers of potential utility? Hum Pathol. 2014 Oct; 45(10):2094-100. PMID: 25130395.

    Read at: PubMed
  • Published on 12/1/2012

    Bae-Harboe YS, Park HY. Tyrosinase: a central regulatory protein for cutaneous pigmentation. J Invest Dermatol. 2012 Dec; 132(12):2678-80. PMID: 23187110.

    Read at: PubMed
  • Published on 12/8/2011

    Yaar M, Park HY. Melanocytes: a window into the nervous system. J Invest Dermatol. 2012 Mar; 132(3 Pt 2):835-45. PMID: 22158549.

    Read at: PubMed
  • Published on 3/1/2011

    Kloxin CJ, Scott TF, Park HY, Bowman CN. Mechanophotopatterning on a photoresponsive elastomer. Adv Mater. 2011 May 3; 23(17):1977-81. PMID: 21360784.

    Read at: PubMed
  • Published on 3/1/2011

    Jung M, Lee S, Park HY, Youm JK, Jeong S, Bae J, Kwon MJ, Park BD, Lee SH, Choi EH. Anti-ageing effects of a new synthetic sphingolipid (K6EAA-L12) on aged murine skin. Exp Dermatol. 2011 Apr; 20(4):314-9. PMID: 21366697.

    Read at: PubMed
  • Published on 11/2/2010

    Park HY, Kim JH, Ji JH, Ahn SK, Hong SP. Variant of phacomatosis pigmentokeratotica. J Dermatol. 2011 Jul; 38(7):719-22. PMID: 21352309.

    Read at: PubMed
  • Published on 6/1/2010

    Byers HR, Boissel SJ, Tu C, Park HY. RNAi-mediated knockdown of protein kinase C-alpha inhibits cell migration in MM-RU human metastatic melanoma cell line. Melanoma Res. 2010 Jun; 20(3):171-8. PMID: 20216103.

    Read at: PubMed
  • Published on 12/30/2009

    Park HY, Wu C, Yaar M, Stachur CM, Kosmadaki M, Gilchrest BA. Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes. Int J Cell Biol. 2009; 2009:750482. PMID: 20130821.

    Read at: PubMed

View 9 more publications: View full profile at BUMC

View all profiles